Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis.
Avani M KollaGerardo A VitielloErica B FriedmanJames SunAishwarya PotdarHala DaouNorma E FarrowClara R FarleyJohn T VettoDale HanMarvi TariqGeorgia M BeasleyCarlo M ContrerasMichael LoweJonathan S ZagerIman OsmanRussell S BermanTracey N LiebmanJennifer A SteinAnn Y LeePublished in: Cancer control : journal of the Moffitt Cancer Center (2022)
In this cohort of patients, acral lentiginous melanoma was associated with poor outcomes even in early stage disease, consistent with prior reports. Stage IIB and IIC disease were associated with particularly low melanoma-specific and recurrence-free survival. This suggests that studies investigating adjuvant therapies in stage II patients may be especially valuable in acral lentiginous melanoma patients.
Keyphrases
- end stage renal disease
- early stage
- newly diagnosed
- free survival
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- emergency department
- patient reported outcomes
- type diabetes
- metabolic syndrome
- skeletal muscle
- weight loss
- neoadjuvant chemotherapy
- skin cancer
- basal cell carcinoma
- sentinel lymph node
- glycemic control